285 related articles for article (PubMed ID: 16081674)
1. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
[TBL] [Abstract][Full Text] [Related]
3. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
4. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
6. Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
Mukherjee S; Adams M; Whiteaker K; Daza A; Kage K; Cassar S; Meyer M; Yao BB
Eur J Pharmacol; 2004 Nov; 505(1-3):1-9. PubMed ID: 15556131
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
Vannacci A; Giannini L; Passani MB; Di Felice A; Pierpaoli S; Zagli G; Fantappiè O; Mazzanti R; Masini E; Mannaioni PF
J Pharmacol Exp Ther; 2004 Oct; 311(1):256-64. PubMed ID: 15187170
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
10. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
Meschler JP; Kraichely DM; Wilken GH; Howlett AC
Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
[TBL] [Abstract][Full Text] [Related]
11. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
Bonhaus DW; Chang LK; Kwan J; Martin GR
J Pharmacol Exp Ther; 1998 Dec; 287(3):884-8. PubMed ID: 9864268
[TBL] [Abstract][Full Text] [Related]
12. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor.
He F; Qiao ZH; Cai J; Pierce W; He DC; Song ZH
Mol Pharmacol; 2007 Nov; 72(5):1289-300. PubMed ID: 17698952
[TBL] [Abstract][Full Text] [Related]
14. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
15. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
[TBL] [Abstract][Full Text] [Related]
16. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.
Carrier EJ; Kearn CS; Barkmeier AJ; Breese NM; Yang W; Nithipatikom K; Pfister SL; Campbell WB; Hillard CJ
Mol Pharmacol; 2004 Apr; 65(4):999-1007. PubMed ID: 15044630
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.
Mancini I; Brusa R; Quadrato G; Foglia C; Scandroglio P; Silverman LS; Tulshian D; Reggiani A; Beltramo M
Br J Pharmacol; 2009 Sep; 158(1):382-91. PubMed ID: 19552692
[TBL] [Abstract][Full Text] [Related]
18. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
19. The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
Alberich Jordà M; Rayman N; Tas M; Verbakel SE; Battista N; van Lom K; Löwenberg B; Maccarrone M; Delwel R
Blood; 2004 Jul; 104(2):526-34. PubMed ID: 15039279
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.
Wang PF; Jiang LS; Bu J; Huang XJ; Song W; Du YP; He B
J Cardiovasc Pharmacol; 2012 Apr; 59(4):301-7. PubMed ID: 22113346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]